Dr. Kimberly Kinga Gokoffski, MD, PhD

Dr. Gokoffski practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Gokoffski's NPI, 1730455353, was assigned on March 28, 2012. Dr. Gokoffski graduated from UC Irvine School of Medicine in 2012. Dr. Gokoffski holds California license A126939.

Dr. Gokoffski's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Gokoffski's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Gokoffski to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gokoffski practices. Vendor and product names are available with a free account.

Neuro-ophthalmology is Dr. Gokoffski's primary specialty in the NPI Registry, under taxonomy code 207WX0109X. Dr. Gokoffski is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Gokoffski is licensed in California.

Dmand AI lists cataract, dry eye, shingles, vision problems and visual impairment and blindness among the conditions Dr. Gokoffski treats.

CMS data shows 563 Medicare services from Dr. Gokoffski across 10 procedure codes in 2024, for 210 Medicare patients. Medicare paid $31,124 for them.

CMS counts 210 Medicare patients who saw Dr. Gokoffski in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 39% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gokoffski's median patient age at 59, with 57% women.

In 2024, Dr. Gokoffski wrote 79 Medicare Part D claims for 26 patients. 63% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $664 in total drug cost. In 2023, CMS named 142 claims across 7 drugs.

Dr. Gokoffski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gokoffski as offering telehealth.

Dmand AI links 11 papers to Dr. Gokoffski, published from 2011 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Autoantibodies. Dr. Gokoffski has published most often in J Neuroophthalmol. Dr. Gokoffski's most frequent co-authors are Lilyana Amezcua, MD, Colin Bacorn, MD and Christine Greer, MD.

CMS Open Payments shows 89 general payments to Dr. Gokoffski from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 45% of the total. Amgen Inc. paid the most, $19,530.

Dr. Gokoffski graduated from UC Irvine School of Medicine in 2012.

Dr. Gokoffski is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.